科济药业-B10月21日耗资约426.98万港元回购25万股

Core Viewpoint - Company Kintor Pharmaceutical (科济药业-B) announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1 - Kintor Pharmaceutical plans to repurchase 250,000 shares at a total cost of approximately HKD 4.2698 million [1] - The buyback is scheduled for October 21, 2025, reflecting the company's strategy to enhance shareholder value [1]